EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Pyrazole-Based Cholinesterase Inhibitors: Medicinal Chemistry Perspectives from 2020 to 2025

Lalsu Yeysin iD, Deniz Akın iD, Süleyman Çalışkan iD, Elvan Hasanoğlu Özkan iD, Hamada Hashem iD, Suleyman Akocak iD, Stefan Bräse iD, Servet Çete

Pharmaceuticals · 13.07.2026 · 19 (7) · 1079

DOI: 10.3390/ph19071079 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 13.07.2026. Verfasst von Lalsu Yeysin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Science, Gazi University, Ankara 06500, Türkiye. Die Arbeit nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyrazole derivatives have attracted considerable interest in medicinal chemistry as adaptable frameworks for developing cholinesterase inhibitors, owing to their advantageous physicochemical properties and structural flexibility. The heteroaromatic characteristics of the pyrazole core allow for various substitution patterns, promoting selective interactions with both the catalytically active site (CAS) and the peripheral anionic site (PAS) of cholinesterase enzymes. These attributes enable pyrazole-based drugs to be viable candidates for the therapy of cognitive disorders, especially Alzheimer’s disease. This study aims to systematically describe medicinal chemistry studies on pyrazole-based cholinesterase inhibitors conducted from 2020 to 2025. The focus is on structural alterations of the pyrazole core and their impact on the inhibitory action against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) using structure–activity relationship (SAR) analysis. Recent advancements in in vitro enzymatic inhibition studies, molecular docking, kinetic analysis, ADME predictions, and multi-target-directed ligand (MTDL) techniques are rigorously evaluated to elucidate trends in potency, selectivity, and drug-like characteristics based on information retrieved from three search engines: Scopus, PubMed, and Google Scholar. This review addresses significant challenges in pharmacokinetics, blood–brain barrier permeability, and safety while delineating prospects for integrating rational design, computational modeling, and biological validation to expedite the development of clinically relevant pyrazole-based cholinesterase inhibitors for Alzheimer’s disease.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseacetylcholinesterasebutyrylcholinesterasedrug designpyrazole

Autor:innen und Institutionen

  • Institute of Science, Gazi University, Ankara 06500, Türkiye.
  • Department of Chemistry, Faculty of Science, Gazi University, Teknikokullar, Ankara 06500, Türkiye.
  • Department of Material Processing Technologies and Polymer Technology, Kırıkkale Vocational School, Kırıkkale University, Kırıkkale 71450, Türkiye.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sohag University, Sohag 82524, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Adıyaman University, Adıyaman 02040, Türkiye.
  • Institute of Biological and Chemical Systems Functional Molecular Systems (IBCS-FMS), Karlsruhe Institute of Technology (KIT), Kaiserstrasse 12, 76131 Karlsruhe, Germany.

ORCID-Profile: Lalsu Yeysin, Deniz Akın, Süleyman Çalışkan, Elvan Hasanoğlu Özkan, Hamada Hashem, Suleyman Akocak, Stefan Bräse

Zitieren

APA

Yeysin, L., Akın, D., Çalışkan, S., Hasanoğlu Özkan, E., Hashem, H., Akocak, S., Bräse, S., & Çete, S. (2026). Recent Advances in Pyrazole-Based Cholinesterase Inhibitors: Medicinal Chemistry Perspectives from 2020 to 2025. Pharmaceuticals, 19(7), 1079. https://doi.org/10.3390/ph19071079

Vancouver

Yeysin L, Akın D, Çalışkan S, Hasanoğlu Özkan E, Hashem H, Akocak S, et al. Recent Advances in Pyrazole-Based Cholinesterase Inhibitors: Medicinal Chemistry Perspectives from 2020 to 2025. Pharmaceuticals. 2026;19(7):1079. doi:10.3390/ph19071079

BibTeX
@article{Yeysin2026,
  author = {Yeysin, Lalsu and Akın, Deniz and Çalışkan, Süleyman and Hasanoğlu Özkan, Elvan and Hashem, Hamada and Akocak, Suleyman and Bräse, Stefan and Çete, Servet},
  title = {Recent Advances in Pyrazole-Based Cholinesterase Inhibitors: Medicinal Chemistry Perspectives from 2020 to 2025},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {7},
  pages = {1079},
  doi = {10.3390/ph19071079}
}
Kostenlos starten →